Antiangiogenesis: A new approach to the treatment of lymphoma

被引：5
作者：
Ganjoo, Kristen [1 ]
机构：
[1] Stanford Univ, Dept Med Oncol, Palo Alto, CA 94304 USA
来源：
LEUKEMIA & LYMPHOMA | 2007年 / 48卷 / 03期
关键词：
D O I：
10.1080/10428190701200059
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：454 / 455
页数：2
相关论文
共 8 条
  • [1] Arias V, 2000, LEUKEMIA LYMPHOMA, V40, P157
  • [2] Rituximab, Bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: Safety, biomarker and pharmacokinetic analysis
    Ganjoo, Kristen N.
    An, Caroline S.
    Robertson, Michael J.
    Gordon, Leo I.
    Sen, Joy A.
    Weisenbach, Jill
    Li, Shuli
    Weller, Edie A.
    Orazi, Attilio
    Horning, Sandra J.
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (06) : 998 - 1005
  • [3] Angiogenesis in non-Hodgkin's lymphoma: Clinico-pathological correlations and prognostic significance in specific subtypes
    Jorgensen, J. M.
    Sorensen, F. B.
    Bendix, K.
    Nielsen, J. L.
    Olsen, M. L.
    Funder, A. M. D.
    D'Amore, F.
    [J]. LEUKEMIA & LYMPHOMA, 2007, 48 (03) : 584 - 595
  • [4] Phase I study of antisense oligonucleotide against vascular endothelial growth factor: Decrease in plasma vascular endothelial growth factor with potential clinical efficacy
    Levine, AM
    Tulpule, A
    Quinn, DI
    Gorospe, G
    Smith, DL
    Hornor, L
    Boswell, WD
    Espina, BM
    Groshen, SG
    Masood, R
    Gill, PS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (11) : 1712 - 1719
  • [5] Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma
    Niitsu, N
    Okamoto, M
    Nakamine, H
    Yoshino, T
    Tamaru, J
    Nakamura, S
    Higashihara, M
    Hirano, M
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 68 (02) : 91 - 100
  • [6] Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients
    Salven, P
    Orpana, A
    Teerenhovi, L
    Joensuu, H
    [J]. BLOOD, 2000, 96 (12) : 3712 - 3718
  • [7] Expression of VEGF, VEGF receptors, and other angiogenic markers in relapsed aggressive non-Hodgkin's lymphoma: Correlative sudies from the SWOG S0108 trial.
    Stopeck, A
    Iannone, M
    Rimsza, L
    Miller, T
    Fisher, R
    Bellamy, W
    [J]. BLOOD, 2004, 104 (11) : 629A - 630A
  • [8] Stopeck AT, 2005, J CLIN ONCOL, V23, p583S
1